JP2011511773A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511773A5
JP2011511773A5 JP2010544697A JP2010544697A JP2011511773A5 JP 2011511773 A5 JP2011511773 A5 JP 2011511773A5 JP 2010544697 A JP2010544697 A JP 2010544697A JP 2010544697 A JP2010544697 A JP 2010544697A JP 2011511773 A5 JP2011511773 A5 JP 2011511773A5
Authority
JP
Japan
Prior art keywords
peptide
composition
cancer
cell
epitopes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010544697A
Other languages
English (en)
Japanese (ja)
Other versions
JP6088123B2 (ja
JP2011511773A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/050996 external-priority patent/WO2009109428A2/en
Publication of JP2011511773A publication Critical patent/JP2011511773A/ja
Publication of JP2011511773A5 publication Critical patent/JP2011511773A5/ja
Application granted granted Critical
Publication of JP6088123B2 publication Critical patent/JP6088123B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010544697A 2008-02-01 2009-01-29 ワクチンとして有用な自己会合ペプチドナノ粒子 Expired - Fee Related JP6088123B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08101221.3 2008-02-01
EP08101221 2008-02-01
PCT/EP2009/050996 WO2009109428A2 (en) 2008-02-01 2009-01-29 Self-assembling peptide nanoparticles useful as vaccines

Publications (3)

Publication Number Publication Date
JP2011511773A JP2011511773A (ja) 2011-04-14
JP2011511773A5 true JP2011511773A5 (https=) 2012-03-08
JP6088123B2 JP6088123B2 (ja) 2017-03-01

Family

ID=39276265

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010544697A Expired - Fee Related JP6088123B2 (ja) 2008-02-01 2009-01-29 ワクチンとして有用な自己会合ペプチドナノ粒子

Country Status (8)

Country Link
US (1) US8546337B2 (https=)
EP (1) EP2235043A2 (https=)
JP (1) JP6088123B2 (https=)
CN (1) CN101932594A (https=)
AU (1) AU2009221419B2 (https=)
CA (1) CA2713879C (https=)
RU (1) RU2540871C2 (https=)
WO (1) WO2009109428A2 (https=)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492400B2 (en) 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
US9267937B2 (en) 2005-12-15 2016-02-23 Massachusetts Institute Of Technology System for screening particles
ES2776100T3 (es) 2006-03-31 2020-07-29 Massachusetts Inst Technology Sistema para el suministro dirigido de agentes terapéuticos
US8367113B2 (en) 2006-05-15 2013-02-05 Massachusetts Institute Of Technology Polymers for functional particles
WO2007150030A2 (en) 2006-06-23 2007-12-27 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
US9217129B2 (en) 2007-02-09 2015-12-22 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
WO2008124632A1 (en) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Amphiphilic compound assisted nanoparticles for targeted delivery
EP2630966B1 (en) 2007-10-12 2017-04-19 Massachusetts Institute of Technology Vaccine nanotechnology
EP2313108A4 (en) * 2008-06-30 2013-06-12 Us Army As Represented By The Secretary Of The Army MALARIA VACCINE FROM SELF-ORGANIZING POLYPEPTIDE NANOTEHICLES
US8277812B2 (en) * 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8591905B2 (en) 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
HUE027823T2 (hu) * 2008-12-09 2016-11-28 Coley Pharm Group Inc Immunstimuláló oligonukleotidok
US8580274B2 (en) 2009-02-10 2013-11-12 University Of The Ryukyus Drug transporter, and adjuvant and vaccine each utilizing same
CA2762653A1 (en) 2009-05-27 2010-12-02 Selecta Biosciences, Inc. Immunomodulatory agent-polymeric compounds
CN107617110A (zh) * 2009-08-26 2018-01-23 西莱克塔生物科技公司 诱导t细胞辅助的组合物
CN102946901A (zh) * 2010-01-26 2013-02-27 科罗拉多大学董事会,法人 模板化成双链卷曲螺旋的呼吸病毒表位及其在免疫中的应用
AU2011258165B2 (en) 2010-05-26 2016-11-17 Selecta Biosciences, Inc. Dose selection of adjuvanted synthetic nanocarriers
WO2012061717A1 (en) 2010-11-05 2012-05-10 Selecta Biosciences, Inc. Modified nicotinic compounds and related methods
US10285942B2 (en) * 2011-04-07 2019-05-14 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Methods of inducing an immune response against HIV by administering immunogenic peptides obtained from protease cleavage sites
JP2014521687A (ja) 2011-07-29 2014-08-28 セレクタ バイオサイエンシーズ インコーポレーテッド 体液性および細胞傷害性tリンパ球(ctl)免疫応答を生成する合成ナノキャリア
EP2748182B1 (en) * 2011-08-23 2016-10-19 President and Fellows of Harvard College Peptide nanoparticles and uses thereof
SI23902A (sl) * 2011-10-07 2013-04-30 Kemijski inštitut Samosestavljivi polipeptidni poliedri
CN104136454A (zh) * 2011-10-12 2014-11-05 阿尔法-O肽股份公司 作为针对诺如病毒感染的疫苗的自装配肽纳米粒
US9550813B2 (en) 2012-05-22 2017-01-24 The Board Of Trustees Of The Leland Stanford Junior University Disulfide stabilized foldon polypeptides
JP2015519348A (ja) * 2012-05-23 2015-07-09 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ インフルエンザワクチン構築物
EP2703483A1 (en) * 2012-08-29 2014-03-05 Affiris AG PCSK9 peptide vaccine
EA201590683A1 (ru) 2012-11-20 2015-11-30 Глаксосмитклайн Байолоджикалс С.А. Тримеры rsv f, предшествующие слиянию
US10248758B2 (en) * 2013-02-07 2019-04-02 University Of Washington Through Its Center For Commercialization Self-assembling protein nanostructures
EP3041478A4 (en) * 2013-09-05 2017-04-26 Immune Design Corp. Vaccine compositions for drug addiction
CN104513293A (zh) * 2013-09-26 2015-04-15 深圳信立泰药业股份有限公司 一种多肽疫苗的盐及其制备方法和含有该盐的药物制品
US10744199B2 (en) 2013-10-11 2020-08-18 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Epstein-Barr virus vaccines
CA2934472A1 (en) * 2014-01-09 2015-07-16 Alpha-O Peptides Ag Flagellin-containing protein nanoparticles as a vaccine platform
EP3134104B1 (en) * 2014-04-25 2018-12-26 Tria Bioscience Corp. Synthetic hapten carrier compositions and methods
EP2974739A1 (en) 2014-07-15 2016-01-20 Novartis AG RSVF trimerization domains
SG11201705264WA (en) * 2014-12-31 2017-07-28 The Usa As Represented By The Secretary Detp Of Health And Human Services Novel multivalent nanoparticle-based vaccines
SG11201706118XA (en) * 2015-01-29 2017-08-30 Agency Science Tech & Res Nanocapsules carrying chikungunya-associated peptides
US10501733B2 (en) 2015-02-27 2019-12-10 University Of Washington Polypeptide assemblies and methods for the production thereof
US9580477B2 (en) 2015-03-16 2017-02-28 The Catholic University Of America Approach to produce HIV-1 GP140 envelope protein trimers
WO2016207782A1 (en) * 2015-06-22 2016-12-29 STRELNIKOV, Evgeny Immunogenic synthetic oligopeptides for a vaccine against hiv
CN105393976A (zh) * 2015-10-30 2016-03-16 河南科技学院 一种利用ghrelin促进新生雏鸡生长性能的方法及应用
CN105210995A (zh) * 2015-10-30 2016-01-06 河南科技学院 一种利用ghrelin促进新生雏鸡免疫器官发育的方法及应用
CN105409831A (zh) * 2015-10-30 2016-03-23 河南科技学院 一种利用ghrelin减少新生雏鸡脂肪细胞分化和降低脂肪沉积的方法及应用
US10188136B2 (en) 2016-02-16 2019-01-29 Indian Institute Of Science Education And Research Hydrophobin mimics: process for preparation thereof
FR3050448A1 (fr) * 2016-04-21 2017-10-27 Bioaster Nanoparticules a base d'encapsuline.
SG11201809387QA (en) 2016-05-02 2018-11-29 Scripps Research Inst Compositions and methods related to hiv-1 immunogens
SG11201901790YA (en) 2016-09-02 2019-03-28 The Usa As Represented By The Secretary Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
BR112019013724A2 (pt) 2017-01-03 2020-04-14 Emergex Vaccines Holding Limited composições de vacina influenza universal
CA3054172A1 (en) 2017-02-23 2018-08-30 Alpha-O Peptides Ag Self-assembling protein nanoparticles encapsulating immunostimulatory nucleid acids
EA201991918A1 (ru) * 2017-03-23 2020-05-15 Альфа-О Пептидс Аг Самосборные белковые наночастицы со встроенными белками с шестиспиральным пучком
WO2019023811A1 (en) 2017-08-04 2019-02-07 The Hospital For Sick Children NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
JP7730640B2 (ja) * 2017-11-01 2025-08-28 ザ スクリプス リサーチ インスティテュート 新規足場hiv-1ワクチン免疫原
EP3744847A4 (en) * 2018-01-22 2021-12-08 Japan as Represented by The Director-General of National Institute of Infectious Diseases SELECTIVE CD8 POSITIVE T CELL INDUCING VACCINE ANTIGEN
US11225502B1 (en) * 2018-06-11 2022-01-18 Battelle Memorial Institute Controlled synthesis of hierarchically-structured hybrid materials through peptoid engineering
CN112469661B (zh) 2018-06-13 2024-04-26 斯克里普斯研究学院 具有新结构组分的纳米粒疫苗
US11213582B2 (en) * 2018-08-08 2022-01-04 The Regents Of The University Of California Protection against recurrent genital herpes by therapeutic immunization with herpes simplex virus type 2 ribonucleotide reductase protein subunits
RU2713723C1 (ru) * 2018-11-15 2020-02-06 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) Искусственные гены, кодирующие белки-иммуногены EV.CTL и EV.Th, рекомбинантные плазмидные ДНК pEV.CTL и pEV.Th, обеспечивающие экспрессию искусственных генов, и искусственные Т-клеточные полиэпитопные белки-иммуногены EV.CTL и EV.Th, содержащие эпитопы антигенов вируса Эбола, используемые для создания вакцины против вируса Эбола
CA3126544A1 (en) 2019-01-12 2020-07-16 The Methodist Hospital Self-assembled peptide nanoparticle and use thereof
KR20220009954A (ko) 2019-04-17 2022-01-25 컴퍼스 패쓰파인더 리미티드 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법
US20220265804A1 (en) * 2019-04-29 2022-08-25 Academy Of Military Medical Sciences Fusion protein capable of self-assembling into protein nanoparticles and application thereof
CN111150841B (zh) * 2019-12-31 2023-08-15 优锐生物医药科技(深圳)有限公司 一种主动免疫调控微粒及其制备方法和应用
CN111150842B (zh) * 2019-12-31 2023-09-05 优锐生物医药科技(深圳)有限公司 一种用于中和胃泌素的主动免疫调控微粒及其制备方法和应用
CN112022066A (zh) * 2020-09-25 2020-12-04 电子科技大学 一种基于深度学习的消化道钩虫发现方法及系统
WO2022106860A1 (en) * 2020-11-20 2022-05-27 Pécsi Tudományegyetem Recombinant peptides for use in therapy
WO2022149609A1 (ja) * 2021-01-07 2022-07-14 国立大学法人東京工業大学 Mhc分子に適合する病原微生物由来のペプチドが担持された複合蛋白質単量体、当該単量体の会合体、及び当該会合体を有効成分とするコンポーネントワクチン、並びに、免疫後の生理活性物質の分泌に関する情報の取得方法
WO2025172892A1 (en) 2024-02-16 2025-08-21 Glaxosmithkline Biologicals Sa Modified proteins and methods
WO2025242657A1 (en) 2024-05-21 2025-11-27 Shape Biopharmaceuticals Ag Lipopeptide building blocks and aggregates
CN119060144B (zh) * 2024-10-31 2025-03-18 南京澄实生物医药科技有限公司 一种预防犬瘟热病毒感染的融合蛋白和疫苗及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK519188D0 (da) * 1988-09-16 1988-09-16 Statens Seruminstitut Kemisk forbindelse
CA2037151A1 (en) * 1990-03-23 1991-09-24 F. Hoffmann-La Roche Ag Plasmodium sporozoite antigen
IL109664A0 (en) 1993-05-18 1994-08-26 Rijksuniversiteit Peptides of human influenza virus for use in human t cell response inducing compositions
JP2002523430A (ja) * 1998-08-21 2002-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ リプレゼンティッド バイ ザ セクレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ 熱帯熱マラリア原虫に対する組換え多価マラリアワクチン
NZ512456A (en) * 1998-11-30 2003-10-31 Cytos Biotechnology Ag Ordered molecular presentation of antigens
US6756039B1 (en) * 1999-05-10 2004-06-29 The Regents Of The University Of California Self assembling proteins
EP1191836B1 (en) * 1999-06-25 2004-09-29 Leslie H. Kondejewski Polypeptide compositions formed using a coiled-coil template and methods of use
EP1303533A2 (en) * 2000-05-05 2003-04-23 Aphton Corporation Chimeric peptide immunogens, their preparation and use
AU2001297913A1 (en) * 2000-10-13 2002-12-23 Ligocyte Pharmaceuticals, Inc. Polyvalent nanoparticles
AU2002349204A1 (en) * 2001-11-26 2003-06-10 University Health Network Self-assembling p53 peptides as gene delivery vehicles
WO2004071493A1 (en) * 2003-02-17 2004-08-26 Peter Burkhard Peptidic nanoparticles as drug delivery and antigen display systems
WO2006033679A2 (en) 2004-05-25 2006-03-30 Chimeracore, Inc. Self-assembling nanoparticle drug delivery system

Similar Documents

Publication Publication Date Title
JP2011511773A5 (https=)
JP2021524275A5 (https=)
JP2018172439A5 (https=)
JP2019513118A5 (https=)
JP2018510147A5 (https=)
CY1117718T1 (el) Διπλα ειδικα απλης αλυσου αντισωματα με ειδικοτητα για υψηλου μοριακου βαρους αντιγονα στοχους
JP2012501959A5 (https=)
IL275567B1 (en) Nucleic acid-containing lipid nano-particle and use thereof
NZ750366A (en) Chimeric antigen receptors targeting bcma and methods of use thereof
JP2021524270A5 (https=)
JP2013541335A5 (https=)
JP2011046722A5 (https=)
JP2019522490A5 (https=)
JP2018523484A5 (https=)
JP2009505676A5 (https=)
JP2014534207A5 (https=)
CY1118303T1 (el) Συγκεκριμενο για διασταυρουμενα-ειδη δι-συγκεκριμενο αντισωμα μονης-αλυσου psmaxcd3
JP2018537415A5 (https=)
JP2010535713A5 (https=)
JP2015143226A5 (https=)
AR069495A1 (es) Construcciones de union de antigenos para el tratamiento de cancer o enfermedades inflamatorias (asma, artritis o artrosis)
JP2010502207A5 (https=)
JP2013079285A5 (https=)
JP2014515602A5 (https=)
JP2017523781A5 (https=)